首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Pathologie

缩写:PATHOLOGIE

ISSN:2731-7188

e-ISSN:2731-7196

IF/分区:0.7/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引486
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ramona Erber,Arndt Hartmann Ramona Erber
Background: Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome is a rare, autosomal dominant tumor predisposition syndrome. It is characterized by the early onset of cutaneous and uterine leiomyomas as we...
Abbas Agaimy,Arndt Hartmann Abbas Agaimy
With the widely increasing implementation of modern next generation sequencing (NGS) technologies in routine molecular pathology practice, the fraction of cancers with a definite or probable hereditary background has been steadily increasin...
Anne Kathrin Höhn,Annette Staebler,Felix K F Kommoss et al. Anne Kathrin Höhn et al.
A number of gynecologic cancers are associated with hereditary cancer syndromes (HCS). These neoplasms may represent the sentinel lesion for HCS within the affected individual/family. Many of these tumors exhibit distinctive histologic and ...
Tiemo S Gerber,Stephanie Strobl,Patrick Focke et al. Tiemo S Gerber et al.
Background: The availability of comparable epidemiological data on malignant tumours remains limited due to heterogeneous classification systems, divergent reference frameworks, and inconsistent case definitions. Incomple...
Laura Grohs,Felix Marbach,Stefan Aretz Laura Grohs
Background: Hereditary tumour disposition syndromes (TDS) are caused by pathogenic germline variants in key genes involved in carcinogenesis and, if left untreated, frequently result in a high lifetime risk for a syndrome...
Michael Heuser,Claudia Wickenhauser,Leonie Oevel et al. Michael Heuser et al.
Background: In acute myeloid leukemia (AML), the monitoring of measurable residual disease (MRD) has evolved over the past two decades from predominantly prognostic supplementary information to a central tool for risk str...